Get started

VIVE - SEP 23

82
VIVE - SEP 23,

fundamentally,

Viveve Announces Issuance of New Method Patent for Stress Urinary Incontinence in Australia

technically ;

has a target at 2.45

SL = 2.35
NART11
Also on:
Fundamental AnalysisTechnical IndicatorsTrend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Fundamental AnalysisTechnical IndicatorsTrend Analysis
NART11
Also on:

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.